glp-1 drugs and alzheimer's failed to slow in two big clinical trials Potential Role of Glucagon-like Peptide-1
Description
It is important to maintain open communication with your healthcare team about any side effects or concerns during GLP-1 treatment
Your prescriber will gradually increase your dosage each week until you reach the target dose of 3 mg daily
Boesmans, W., Owsianik, G., Tack, J., Voets, T
Miyamoto, S
The American journal of clinical nutrition , 92 (4), 810-817
Efficacy and safety of co-administered once-weekly cagrilintide 2 4 mg with once-weekly semaglutide 2 4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
